F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review the facility failed to follow their policy for one of three sampled residents
(Resident 1) when informed consent was not provided by resident or representative prior to psychotropic
medication was administered (medications that affects mind, emotion and behavior).
Residents Affected - Few
This failure resulted in Residents 1's representative rights to be violated and risks, benefits, adverse
reactions and right to refuse the administration of the medication.
Findings:
During review of Residents 1's admission Record (general demographics), the document indicated
Resident 1 was admitted to the facility on [DATE], with diagnoses to include: senile degeneration of brain
(mental deterioration, loss of intellectual ability), palliative care (specialized care for people with serious
illness), unspecified dementia (impaired ability to remember, think or make decisions), anxiety (feeling of
fear, feeling tense and restless), delirium (mental state of confusion, disoriented, and lack of awareness).
During a concurrent interview and record review of Resident 1's with the Director of Nursing (DON),
reviewed are as follows:
1. Physician Telephone Order (Hospice) Dated July 27, 2023, Medication Order: Haloperidol (antipsychotic
medication used to treat certain types on mental disorders) LAC 5 mg/mL vial inject 1 mL IM every 6 hours
as needed .Signed July 28, 2023.
2. Documents: Apple Valley Care Center, Facility Verification of Residents Informed Consent
Psychotherapeutic Drugs of Prolonged Use of Device Dated July 27, 2023: Resident Representative as
Charter Hospice [Name] Registered Nurse, Relationship: [Name] Registered .Nurse receiving Order
[Name] Registered Nurse .doctor signature dated July 28, 2023. (No resident or Resident Representative
(spouse) signature of consent noted).
3. Medication Administration Record (MAR) July 2023: Haldol injection 5mg/mL, inject 1 mL intramuscularly
every 6 hours as needed for r/t agitation, Administered July 28, 2023, at 11:12 and 1754.
During an interview with the Director of Nursing DON (DON), the DON stated, The hospice nurse told me
she called the wife for Haldol consent. I will not give medication if there is not a verbal or a signed consent.
The hospice nurse told me she was the one who called the wife to get the consent, but I see the document,
she [the hospice nurse] signed on the wrong space, it has her name in the resident representative. When
asked, based on this document reviewed does it state the wife was called
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
555476
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555476
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/28/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Apple Valley Care Center
11959 Apple Valley Rd
Apple Valley, CA 92308
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
and a verbal consent was given? No, it has the hospice nurse on both lines on the consent form.
Level of Harm - Minimal harm
or potential for actual harm
During a review of the facility's policy and procedure titled, Verification of Informed Consent for
Psychotherapeutic Medications revised May 2024, the policy and procedure indicated: Policy Statement:
Each resident has the right to be free from psychotherapeutic drugs and, to provide informed consent
before treatment with psychotherapeutic drugs. Informational materials concerning psychotherapeutic
drugs. The facility will obtain a written informed consent for treatment using psychotherapeutic drugs and
consent renewal every six months .Procedure 2. If the resident or resident's representative cannot sign the
informed consent form, a licensed nurse can sign the form and document the name of the person who gave
consent and the date. The personal exam and the signatures of the prescriber, resident, or representative
can be completed and signed using remote technology. 4.Signed written consent will be recorded in the
resident's medical record. Before initiating treatment with psychotherapeutic drugs, facility staff must verify
that the president's health record contains written informed consent with the required signatures.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555476
If continuation sheet
Page 2 of 2